z-logo
Premium
Ferumoxytol vs. Gadolinium agents for contrast‐enhanced MRI: Thoughts on evolving indications, risks, and benefits
Author(s) -
Finn J. Paul,
Nguyen KimLien,
Hu Peng
Publication year - 2017
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.25580
Subject(s) - nephrogenic systemic fibrosis , medicine , gadolinium , ferumoxytol , magnetic resonance imaging , radiology , chemistry , organic chemistry

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom